GlaxoSmithKline (GSK) is a British multinational pharmaceutical company formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham. Its roots trace back to the 18th century, and it has grown through key product innovations and strategic acquisitions to become one of the world's largest drug companies.
Silvanus Bevan founds Plough Court pharmacy in London, later evolving into SmithKline & French. #history #pharma
John K. Smith opens a drugstore in Philadelphia, founding what becomes Smith, Kline & French. #history #pharma
Thomas Beecham starts selling his Beecham's Pills, a laxative, in St. Helens, England. #pharma #heritage )
Beecham's Pills are officially launched, becoming a best-selling patent medicine. #pharma #history )
Joseph Nathan establishes a trading company in New Zealand, which later develops Glaxo infant milk powder. #history #pharma )
Henry Wellcome and Silas Burroughs found Burroughs Wellcome & Co. in London. #pharma #history
Joseph Nathan & Co. introduces Glaxo as a brand for dried milk powder. #pharma #brand
Glaxo Laboratories is established as a separate company to handle manufacturing. #pharma #history
Glaxo Laboratories goes public, raising capital for expansion. #finance #pharma
SmithKline & French acquires Laboratoires SmithKline & French in France, expanding in Europe. #acquisition #pharma
Beecham launches ampicillin, the first broad-spectrum penicillin. #innovation #pharma )
SmithKline's Tagamet (cimetidine) receives FDA approval, becoming the first blockbuster ulcer drug. #pharma #breakthrough
Glaxo launches Zantac (ranitidine), which becomes the world's best-selling prescription drug. #pharma #blockbuster
SmithKline Corporation merges with Beckman Instruments to form SmithKline Beckman. #merger #pharma
Burroughs Wellcome's AZT (zidovudine) receives FDA approval as the first HIV treatment. #pharma #HIV
Beecham Group merges with SmithKline Beckman to form SmithKline Beecham. #merger #pharma
SmithKline Beecham launches the antidepressant Paxil (paroxetine). #pharma #drug
Glaxo plc merges with the Wellcome Foundation to form Glaxo Wellcome. #merger #pharma
Glaxo Wellcome's Advair Diskus (fluticasone/salmeterol) receives FDA approval for asthma. #pharma #innovation
Glaxo Wellcome and SmithKline Beecham merge to create GlaxoSmithKline (GSK). #merger #pharma
GlaxoSmithKline lists its shares on the New York Stock Exchange. #finance #pharma
GSK's Advair becomes the world's best-selling asthma drug, generating billions. #pharma #blockbuster
GSK pays $2.5 billion to settle US allegations of fraud and anticompetitive conduct regarding Paxil. #legal #pharma
GSK acquires Reliant Pharmaceuticals for $1.65 billion, gaining cardiovascular drugs. #acquisition #pharma
GSK's Cervarix (HPV vaccine) receives EU approval for cervical cancer prevention. #vaccine #pharma
GSK acquires Stiefel Laboratories for $2.9 billion, expanding dermatology. #acquisition #pharma
GSK agrees to pay $3 billion to settle US investigations into Avandia marketing. #legal #pharma
CEO Andrew Witty announces restructuring, including job cuts and divestitures. #strategy #pharma
GSK sells thrombosis drugs to Aspen Pharmacare for £700 million. #divestiture #pharma
GSK is fined $490 million for bribery in China, causing global reputational damage. #legal #china
GSK and Novartis complete a major asset swap, with GSK selling its oncology business. #deal #pharma
GSK's Shingrix vaccine for shingles is approved, becoming a blockbuster. #vaccine #pharma
Emma Walmsley takes over as GSK's first female CEO, focusing on innovation. #leadership #pharma
GSK acquires Tesaro for $5.1 billion to boost its oncology pipeline. #acquisition #pharma
GSK announces plans to separate into two companies: one for pharma/vaccines and one for consumer health. #strategy #pharma
GSK collaborates with multiple partners on COVID-19 vaccine adjuvants. #pandemic #vaccine
GSK lists its consumer healthcare joint venture Haleon on the LSE, selling a stake. #ipo #divestiture
GSK spins off Haleon, creating a standalone consumer health company. #demerger #pharma
GSK acquires Bellus Health for $2 billion, adding a late-stage cough drug. #acquisition #pharma
GSK announces that Emma Walmsley will step down as CEO, with a successor to be named. #leadership #pharma